Diffusion Optics Technology (DOT): A Myopia Control Spectacle Lens Based on Contrast Theory.

IF 2.6 3区医学 Q2 OPHTHALMOLOGY

Translational Vision Science & Technology Pub Date : 2024-10-01 DOI:10.1167/tvst.13.10.42

Jay Neitz, Maureen Neitz

引用次数: 0

Abstract

Diffusion optics Technology (DOT) myopia control spectacle lenses are based on contrast theory. This innovative theory represents a radical departure from the classical concept of visual deprivation myopia. However, traditional theories have evolved, arriving at remarkably similar solutions for myopia control as the DOT lenses. Nonetheless, contrast theory still represents a departure from mainstream theories. Here, in an effort to resolve discrepancies, we review the science behind contrast theory and compare it to more conventional blur and defocus theories. Finally, we consider the implications of the different theories for the rational design of myopia control solutions.

查看原文本刊更多论文

扩散光学技术（DOT）：基于对比理论的近视控制眼镜片。

扩散光学技术（DOT）近视控制眼镜片以对比度理论为基础。这一创新理论与传统的视觉剥夺近视概念截然不同。然而，传统的理论也在不断发展，其近视控制解决方案与 DOT 镜片极为相似。尽管如此，对比理论仍然代表着与主流理论的背离。在此，为了消除差异，我们回顾了对比度理论背后的科学原理，并将其与更传统的模糊和散焦理论进行了比较。最后，我们将探讨不同理论对合理设计近视控制方案的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Translational Vision Science & Technology Engineering-Biomedical Engineering

CiteScore

5.70

自引率

3.30%

发文量

346

审稿时长

25 weeks

期刊介绍： Translational Vision Science & Technology (TVST), an official journal of the Association for Research in Vision and Ophthalmology (ARVO), an international organization whose purpose is to advance research worldwide into understanding the visual system and preventing, treating and curing its disorders, is an online, open access, peer-reviewed journal emphasizing multidisciplinary research that bridges the gap between basic research and clinical care. A highly qualified and diverse group of Associate Editors and Editorial Board Members is led by Editor-in-Chief Marco Zarbin, MD, PhD, FARVO. The journal covers a broad spectrum of work, including but not limited to: Applications of stem cell technology for regenerative medicine, Development of new animal models of human diseases, Tissue bioengineering, Chemical engineering to improve virus-based gene delivery, Nanotechnology for drug delivery, Design and synthesis of artificial extracellular matrices, Development of a true microsurgical operating environment, Refining data analysis algorithms to improve in vivo imaging technology, Results of Phase 1 clinical trials, Reverse translational ("bedside to bench") research. TVST seeks manuscripts from scientists and clinicians with diverse backgrounds ranging from basic chemistry to ophthalmic surgery that will advance or change the way we understand and/or treat vision-threatening diseases. TVST encourages the use of color, multimedia, hyperlinks, program code and other digital enhancements.